首页|期刊导航|中草药|薯蓣皂苷元丝素蛋白纳米粒的制备、表征及其对前列腺癌荷瘤裸鼠肿瘤的抑制作用

薯蓣皂苷元丝素蛋白纳米粒的制备、表征及其对前列腺癌荷瘤裸鼠肿瘤的抑制作用OA

Preparation and characterization of diosgenin silk fibroin nanoparticles and their inhibitory effects on tumors in prostate cancer-bearing nude mice

中文摘要英文摘要

目的 制备薯蓣皂苷元丝素蛋白纳米粒(diosgenin silk fibroin nanoparticles,Doi-SF-NPs),并进行理化性质、肿瘤靶向性和体内抗肿瘤作用评价.方法 单因素考察Doi-SF-NPs主要影响因素,采用Box-Behnken设计-响应面法(Box-Behnken design-response surface methodology,BBD-RSM)优化 Doi-SF-NPs 处方工艺.使用透射电子显微镜(transmission electron microscopy,TEM)和傅里叶变换红外光谱(Fourier transform infrared spectroscopy,FT-IR)法进行表征.考察 Doi-SF-NPs在不同pH值磷酸盐缓冲液(PBS)中的释药行为.采用MTT法和AnnexinV/PI双染法考察Doi-SF-NPs对人前列腺癌PC3细胞的生长抑制及促凋亡作用.建立前列腺癌荷瘤裸鼠模型,比较薯蓣皂苷元原料药和Doi-SF-NPs在肿瘤组织中质量浓度,采用相对摄取率和峰浓度比值考察Doi-SF-NPs肿瘤靶向性.将前列腺癌荷瘤裸鼠分为模型(生理盐水)组、阳性对照(顺铂,2.0mg/kg)组、薯蓣皂苷元原料药(10mg/kg)组及Doi-SF-NPs低、高剂量(5、10mg/kg)组,比较Doi-SF-NPs体内抗肿瘤效果.评价Doi-SF-NPs安全性.结果 Doi-SF-NPs最佳处方:丝素蛋白与薯蓣皂苷元质量比为11.94∶1,有机相与水相体积比为5.99∶1,制备时间为2.75h.Doi-SF-NPs平均包封率、载药量、粒径和ζ电位分别(84.07±0.70)%、(6.41±0.05)%、(164.29±4.43)nm和(-23.01±1.17)mV.薯蓣皂苷元与丝素蛋白通过氢键络合作用形成Doi-SF-NPs.Doi-SF-NPs外貌呈类圆形纳米颗粒.Doi-SF-NPs在pH 5.5、6.0 PBS中累积释放度较高,具有明显的pH值敏感性.薯蓣皂苷元原料药和 Doi-SF-NPs 对 PC3 细胞半数抑制浓度(median inhibition concentration,IC50)分别为 72.44、55.68 μmol/L.Doi-SF-NPs 比薯蓣皂苷元原料药更有效地诱导了 PC3细胞凋亡.Doi-SF-NPs在肿瘤组织内相对摄取率为3.23,峰浓度比值为2.60,证明Doi-SF-NPs能明显增加肿瘤组织的蓄积量.Doi-SF-NPs(10mg/kg)将薯蓣皂苷元原料药(10mg/kg)抑瘤率由29.47%提高至66.18%.Doi-SF-NPs未对荷瘤裸鼠主要脏器产生影响,使用安全性高.结论 Doi-SF-NPs可提高薯蓣皂苷元肿瘤靶向性,显著提高了抗肿瘤药效,有望开发成抗肿瘤药物.

Objective To prepare diosgenin silk fibroin nanoparticles(Doi-SF-NPs)and evaluate their physicochemical properties,tumor targeting and in vivo anti-tumor effects.Methods The main influencing factors of Doi-SF-NPs were investigated by single factor experiments,and Box-Behnken design-response surface methodology(BBD-RSM)was employed to optimize prescription process of Doi-SF-NPs.Doi-SF-NPs was characterized by transmission electron microscopy(TEM)and Fourier transform infrared spectroscopy(FT-IR).Drug release behavior of Doi-SF-NPs in phosphate buffer saline solution with different pH values was investigated.MTT method and Annexin V/PI double staining method were used to investigate the inhibitory and proapoptotic effects of Doi-SF-NPs on PC3 cells,respectively.The nude mouse of prostate cancer was established,compared the concentrations of diosgenin and Doi-SF-NPs in tumor tissues,and then evaluated the tumor targeting ability of Doi-SF-NPs using the relative uptake rate and ratio of peak concentration.The nude mouse model of prostate cancer was divided into model(normal saline)group,positive control(cisplatin,2.0 mg/kg)group,diosgenin(10 mg/kg)group,low-dose Doi-SF-NPs(5 mg/kg)group and high-dose Doi-SF-NPs(10 mg/kg)group,the in vivo anti-tumor effects of Doi-SF-NPs was compared with diosgenin.Safety evaluation of Doi-SF-NPs was also performed.Results Optimal prescription process of Doi-SF-NPs nanoparticles as follows:The mass ratio of silk fibroin to diosgenin was 11.94∶1,the volume ratio of the organic phase to aqueous phase was 5.99∶1,and the preparation time was 2.75 h.Average envelopment efficiency,drug loading,particle size and ζ potential were(84.07±0.70)%,(6.41±0.05)%,(164.29±4.43)nm and(-23.01±1.17)mV,respectively.Diosgenin formed Doi-SF-NPs with silk fibroin through hydrogen bonding.The appearance of Doi-SF-NPs was spherical nanoparticles.Doi-SF-NPs existed higher cumulative release in phosphate buffer solution of pH 5.5 and 6.0,which demonstrated that Doi-SF-NPs had obvious pH-sensitivity.MTT method results showed that IC50 of diosgenin and Doi-SF-NPs on PC3 cells were 72.44 and 55.68 μmol/L,respectively.Doi-SF-NPs more effectively induced apoptosis of PC3 cells than that of diosgenin.The relative uptake rate of Doi-SF-NPs in in tumor tissue was 3.23,and the peak concentration ratio was 2.60,which demonstrating that Doi-SF-NPs could significantly increase the accumulation in tumor tissue.Doi-SF-NPs(10 mg/kg)increased the tumor inhibition rate of diosgenin(10 mg/kg)from 29.47%to 66.18%.Doi-SF-NPs did not affect the major organs of tumor-bearing nude mouse,which showed that the safety of Doi-SF-NPs was high.Conclusion Doi-SF-NPs could improve the tumor targeting of diosgenin and significantly enhanced anti-tumor efficacy.Therefore,Doi-SF-NPs had the potential to be developed into an antitumor drug.

董亚楠;任书强;石岩;董娇娇;王风云

河南应用技术职业学院,河南郑州 450042郑州健康学院,河南郑州 450064郑州市中心医院,河南郑州 450001北京大学肿瘤医院,北京 100002河南应用技术职业学院,河南郑州 450042

医药卫生

薯蓣皂苷元丝素蛋白纳米粒Box-Behnken设计-响应面法前列腺癌肿瘤靶向抗肿瘤安全性评价

diosgeninsilk fibroinnanoparticlesBox-Behnken design-response surface methodologyprostate cancertumor targetinganti-tumorsafety evaluation

《中草药》 2026 (19)

7587-7601,15

2025年度河南省高等学校重点科研项目(25B310010)2024年度河南应用技术职业学院校级科研课题(2024-KJ-69)2025年度河南省科技攻关课题(252102310468)2026年度河南省科技攻关课题(262102310551)

10.7501/j.issn.0253-2670.2026.19.009

评论